title: Recommendations pertaining to the use of influenza vaccines and influenza antiviral drugs, 2016.
abstract: Vaccination is the most effective strategy to prevent influenza. It is recommended that influenza vaccine be administered each year before the influenza season, i.e. from March to June, although for individuals at increased risk of severe influenza in whom vaccination was missed, vaccine may be administered later. For a review of the 2015 influenza season and ongoing real-time updates of the 2016 influenza season when it starts, refer to the website of the National Institute for Communicable Diseases of the National Health Laboratory Service (www.nicd.ac.za). In this article we provide recommendations for the use of influenza vaccines in anticipation of the 2016 Southern Hemisphere influenza season. Guidance is based on available evidence to assist clinicians in making decisions regarding influenza vaccination. It should be noted that this article includes general recommendations for vaccination with influenza vaccines available in South Africa and may differ from groups targeted in specific vaccination programmes, e.g. the National Department of Health Programme.
authors.affiliation: Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa. sibongilew@nicd.ac.za.
authors.forename: Sibongile
authors.initials: S
authors.lastname: Walaza
authors.forename: Cheryl
authors.initials: C
authors.lastname: Cohen
mesh_terms: D000367:Age Factors; D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control; D009975:Orthomyxoviridae / Q000187:drug effects / Q000302:isolation & purification; D012307:Risk Factors; D012621:Seasons; D013019:South Africa / Q000453:epidemiology; D014611:Vaccination / Q000379:methods*
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines